These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20228273)

  • 21. Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.
    Whyte CS; Swieringa F; Mastenbroek TG; Lionikiene AS; Lancé MD; van der Meijden PE; Heemskerk JW; Mutch NJ
    Blood; 2015 Apr; 125(16):2568-78. PubMed ID: 25712989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.
    Bjerregaard N; Bøtkjær KA; Helsen N; Andreasen PA; Dupont DM
    Thromb Haemost; 2015 Jul; 114(1):139-49. PubMed ID: 25855589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma fibronectin enhances fibrinolytic system in vitro.
    Gilboa N; Kaplan JE
    Thromb Haemost; 1985 Oct; 54(3):639-44. PubMed ID: 2935966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.
    Kovács A; Szabó L; Longstaff C; Tenekedjiev K; Machovich R; Kolev K
    Thromb Res; 2014 Jan; 133(1):80-7. PubMed ID: 24094605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasminogen activation by tissue plasminogen activator on fibrin clots with different surface structures].
    Savchuk AN
    Ukr Biokhim Zh (1999); 2001; 73(3):87-90. PubMed ID: 12035559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of tPA-dependent provisional extracellular fibrin matrix degradation by human recombinant soluble melanotransferrin.
    Bertrand Y; Demeule M; Rivard GE; Béliveau R
    Biochim Biophys Acta; 2006 Oct; 1763(10):1024-30. PubMed ID: 16979249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyphosphate enhances fibrin clot structure.
    Smith SA; Morrissey JH
    Blood; 2008 Oct; 112(7):2810-6. PubMed ID: 18544683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin.
    Higgins DL; Vehar GA
    Biochemistry; 1987 Dec; 26(24):7786-91. PubMed ID: 2962641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies.
    Longstaff C; Thelwell C; Williams SC; Silva MM; Szabó L; Kolev K
    Blood; 2011 Jan; 117(2):661-8. PubMed ID: 20966169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of the effect of ultrasound on the fibrinolysis of clots.
    Chernysh IN; Everbach CE; Purohit PK; Weisel JW
    J Thromb Haemost; 2015 Apr; 13(4):601-9. PubMed ID: 25619618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clot penetration and retention by plasminogen activators promote fibrinolysis.
    Marcos-Contreras OA; Ganguly K; Yamamoto A; Shlansky-Goldberg R; Cines DB; Muzykantov VR; Murciano JC
    Biochem Pharmacol; 2013 Jan; 85(2):216-22. PubMed ID: 23098998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
    Talbot K; Meixner SC; Pryzdial EL
    Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Size- and charge-dependent modulation of the lytic susceptibility and mechanical stability of fibrin-histone clots by heparin and polyphosphate variants.
    Komorowicz E; Balázs N; Tanka-Salamon A; Varga Z; Szabó L; Bóta A; Longstaff C; Kolev K
    J Thromb Haemost; 2021 May; 19(5):1307-1318. PubMed ID: 33609065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease.
    Kwieciński J; Josefsson E; Jin T
    Inflamm Res; 2011 Nov; 60(11):1021-9. PubMed ID: 21786185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [PC-12 cells hydrolyze the fibrin clot by producing both plasminogen and its tissue activator].
    Petrova IuI; Savchuk OM; Kalashnyk OM; Platonova TM; Skok MV; Cederholm-Williams S
    Ukr Biokhim Zh (1999); 2004; 76(2):64-8. PubMed ID: 15915713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity.
    Mitchell JL; Lionikiene AS; Georgiev G; Klemmer A; Brain C; Kim PY; Mutch NJ
    Blood; 2016 Dec; 128(24):2834-2845. PubMed ID: 27694320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.